|1.||Maniwa, Yoshimasa: 4 articles (11/2008 - 01/2005)|
|2.||Lieberman, Howard B: 3 articles (11/2012 - 03/2008)|
|3.||Zhu, Aiping: 3 articles (11/2012 - 03/2008)|
|4.||Okita, Yutaka: 3 articles (11/2008 - 01/2005)|
|5.||Okada, Kenji: 3 articles (11/2008 - 01/2005)|
|6.||Hayashi, Yoshitake: 3 articles (11/2008 - 01/2005)|
|7.||Broustas, Constantinos G: 2 articles (11/2012 - 02/2011)|
|8.||Nishimura, Yoshihiro: 2 articles (11/2008 - 03/2006)|
|9.||Yuki, Takeshi: 2 articles (11/2008 - 01/2005)|
|10.||Kanomata, Naoki: 2 articles (03/2006 - 01/2005)|
11/30/2012 - "Rad9 protein contributes to prostate tumor progression by promoting cell migration and anoikis resistance."
02/01/2011 - "These results reveal that RAD9 protein can function as an oncogene or tumor suppressor, and aberrantly high or low levels can have deleterious health consequences. "
03/01/2008 - "There was a strong correlation between Rad9 protein abundance and cancer stage. "
03/01/2008 - "Rad9 protein levels were high in 153 of 339 human prostate tumor biopsy samples examined and detectable in only 2 of 52 noncancerous prostate tissues. "
01/01/2008 - "Localisation of hRad9 protein were performed on paired tumor and normal breast tissues. "
|2.||Breast Neoplasms (Breast Cancer)
01/01/2014 - "Over expression of hRad9 protein correlates with reduced chemosensitivity in breast cancer with administration of neoadjuvant chemotherapy."
01/01/2008 - "Increased hRad9 protein was observed in breast cancer cells nucleus compared to non-tumor epithelium. "
01/02/1997 - "13, 266-267] has emphasized the potential importance of the BRCA1 C-terminal region for BRCA1-mediated breast cancer suppression, as this domain shows similarities with the C-terminal regions of a p53-binding protein (53BP1), the yeast RAD9 protein involved in DNA repair, and two uncharacterized, hypothetical proteins (KIAA0170 and SPAC19G10.7). "
|3.||Acute Lung Injury
|4.||Prostatic Neoplasms (Prostate Cancer)
03/01/2008 - "Rad9 protein level can thus provide a biomarker for advanced prostate cancer and is causally related to the disease, suggesting the potential for developing novel diagnostic, prognostic, and therapeutic tools based on detection or manipulation of Rad9 protein abundance."
03/01/2008 - "We found that four prostate cancer cell lines (CWR22, DU145, LNCaP, and PC-3), relative to PrEC normal prostate cells, have aberrantly high levels of Rad9 protein. "
|5.||Lung Neoplasms (Lung Cancer)
|1.||Proteins (Proteins, Gene)
|1.||Drug Therapy (Chemotherapy)